Alpine Immune Sciences Inc (ALPN) Return on Assets ROA from the first quarter of 2024 to first quarter of 2023 and for the year 2024, Average High and Low, Fundamental Ratios from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alpine Immune Sciences Inc   (NASDAQ: ALPN)


Alpine Immune Sciences Inc 's ROA from the first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Alpine Immune Sciences Inc 's ROA in the first quarter of 2024?
Alpine Immune Sciences Inc recorded a cumulative net loss of $-37 million during 12 months ending in the first quarter of 2024, resulting in a negative return on assets (ROA) of -12.07%.

However, within the Healthcare sector 294 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2024 quarter, so far to 3536, from total ROA ranking in the fourth quarter of 2023 at 4044.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Total Assets Change 43.58 % 33.21 % -17.41 % 18.58 % 12.73 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -37 -32 -57 -59 -64
Return On Assets (TTM) -12.07 % -11.6 % -22.43 % -21.97 % -24.72 %
ALPN's Total Ranking # 3536 # 4044 # 3914 # 3954 # 4155
Total Assets (TTM) in million 367 373 234 247 256
Seq. Total Assets Change -1.61 % 59.13 % -4.91 % -3.56 % -8.72 %
Seq. Net Income Change - - - - -

ALPN's 5 Years Annual ROA >> Back to ALPN Management Effectiveness >> Compare ALPN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 97
Sector # 295
Overall # 3479

Return On Assets Statistics
High Average Low
-3.78 %
-30.26 %
-74.07 %
(Sep 30 2017)   (Jun 30 2019)





Financial Statements
Alpine Immune Sciences Inc 's Assets $ 367 million ALPN's Balance sheet
Alpine Immune Sciences Inc 's Income $ -18 million Quarterly ALPN's Income Statement
ALPN's Income by Division See ALPN's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019
Y / Y Total Assets Change 33.21 % 12.66 % 82.21 % 152.22 % -1.42 %
Total Assets in million 373 280 249 136 54
Y / Y Net Income Change - - - - -
Net Income in million -32 -58 -50 -28 -42
Annual Return On Assets -8.63 % -20.63 % -20.25 % -20.48 % -77.37 %

ALPN's 5 Years Annual ROA >> Back to ALPN Management Effectiveness >> Compare ALPN ROA to its Competitors



More Return On Assets Ratios
ALPN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ALPN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ALPN's Competitors
Subscribers only: Roa for Alpine Immune Sciences Inc 's Suppliers
Subscribers only: Return On Assets for ALPN's Customers

You may also want to know
ALPN's Roi ALPN's Inventory Turnover Ratio ALPN's Growth Rates ALPN's Dividend Comparisons
ALPN's Profitability Ratios ALPN's Asset Turnover Ratio ALPN's Dividend Growth
ALPN's Roe ALPN's Valuation Ratios ALPN's Financial Strength Ratios ALPN's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2024, within Healthcare Sector ROA

Date modified: 2026-09-26T07:20:48+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.